4crt: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{STRUCTURE_4crt| PDB=4crt | SCENE= }} | |||
===Crystal structure of human monoamine oxidase B in complex with the multi-target inhibitor ASS234=== | |||
{{ABSTRACT_PUBMED_24642166}} | |||
==Function== | |||
[[http://www.uniprot.org/uniprot/AOFB_HUMAN AOFB_HUMAN]] Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. MAOB preferentially degrades benzylamine and phenylethylamine. | |||
==About this Structure== | |||
[[4crt]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CRT OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:024642166</ref><references group="xtra"/><references/> | |||
[[Category: Monoamine oxidase]] | |||
[[Category: Allan, J.]] | |||
[[Category: Binda, C.]] | |||
[[Category: Esteban, G.]] | |||
[[Category: Marco-Contelles, J.]] | |||
[[Category: Mattevi, A.]] | |||
[[Category: Ramsay, R R.]] | |||
[[Category: Samadi, A.]] | |||
[[Category: Unzeta, M.]] | |||
[[Category: Alzheimer's disease]] | |||
[[Category: Drug design]] | |||
[[Category: Enzyme]] | |||
[[Category: Flavin]] | |||
[[Category: Oxidoreductase]] |